MedCap AB (MEDCAP)

Currency in SEK
651.000
+21.000(+3.33%)
Closed·

MEDCAP Financial Summary

Key Ratios

P/E Ratio49.09
Price/Book7.22
Debt / Equity24.59%
Return on Equity15.95%
Dividend Yield0.00%
EBITDA304.90M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2016
30/04
2017
30/04
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of SEK (except for per share items)

Earnings

Latest Release
Jul 23, 2025
EPS / Forecast
3.60 / 3.50
Revenue / Forecast
521.85M / 506.97M
EPS Revisions
Last 90 days

FAQ

What were MedCap's earnings for the latest quarter?

The MedCap EPS (TTM) is 13.32. MedCap reported sales of 521.70, net income of 53.60, and EPS of 3.60 for the latest quarter.

What was MedCap's net income for the latest quarter?

MedCap's net income for the latest quarter was 53.60.

How did MedCap's performance compare year-over-year in the latest quarter?

The company's revenue moved from 493.80 in the previous quarter to 521.70 in the latest quarter, and net income moved from 50.50 to 53.60 compared to the previous quarter.

What is MedCap's net profit margin on a TTM basis?

MedCap's trailing twelve months (TTM) net profit margin is 11.48%.

How does MedCap's debt to equity ratio compare to industry standards?

MedCap's total debt-to-equity ratio is 24.59%.

What is MedCap's return on investment on a TTM basis?

MedCap's trailing twelve months (TTM) return on investment (ROI) is 15.95%.

Did MedCap gain or lose cash last quarter?

In the latest quarter, MedCap's net change in cash was 19.90 million.

What were MedCap's total assets and liabilities in the latest quarter?

As of the latest quarter, MedCap reported total assets of 2,090.40 million and total liabilities of 371.10 million.

How has MedCap's total revenue grown this year?

MedCap's total revenue was 493.80 in the previous quarter and 521.70 in the latest quarter.

What is MedCap's gross margin on a TTM basis?

MedCap's trailing twelve months (TTM) gross margin is 58.16%.

What was MedCap's revenue per share for the latest quarter?

MedCap's revenue per share for the latest quarter was 20.46.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.